Latest Corporate News


MONTREAL, QC, June 20h, 2017 – Pharmascience Inc., the largest pharmaceutical employer in Quebec with a presence in over 60 countries, acknowledges the issuance of a non-compliant rating given by Health Canada following an inspection of its Royalmount facility on February 13th, 2017. Pharmascience’s Establishment License and Certificate of Compliance are not impacted by this rating and as such, it will continue to manufacture, sell and distribute its products globally with the highest degree of care and quality.

Pharmascience has taken prompt and rigorous corrective actions to address the concerns of Health Canada. Pharmascience has been actively collaborating with Health Canada in addressing their concerns and is prepared for a follow up inspection to confirm the implementation and effectiveness of its remediation actions. 

“Our teams responded with quick and rigorous corrective measures, and I am proud of our employees’ efforts”, said Dr. David Goodman, Chief Executive Officer. “Compliance is an evolving process and we’ve seized this opportunity to further strengthen our compliance profile and have significantly strengthened our quality leadership, systems and processes”.

Pharmascience has a proud 35 year history of diligently serving patients in Canada and abroad and will continue to manufacture its products with the highest degree of care and quality. Significant and recent investments in people, systems, facilities and processes underscore its commitment to continue supplying the global market with high-quality medicine made in Montreal. As a major contributor to health care in Canada and abroad, we reiterate our focus on continuing to invest locally to ensure that our capability to research, develop, produce and distribute drugs from our Montreal facility is sustained. 

About Pharmascience Inc.

Founded in 1983, Pharmascience Inc. is the largest pharmaceutical employer in Quebec with over 1 500 employees proudly headquartered in Montreal. Pharmascience Inc. is a full-service privately owned pharmaceutical company with strong roots in Canada and a growing global reach with product distribution in over 60 countries. Ranked 57th among Canada?s top 100 research & development (R&D) investors with over $44 million invested in 2015, Pharmascience Inc. is the 10th largest pharmaceutical company in Canada. Pharmascience Inc. has strong values which are based on the importance of investing in the personal development and life of employees and young people. At the beginning of 2017, Pharmascience Inc. has proudly been recognized for its investments by being selected as one of Canada?s Top Employers for Young People and named as one of Montreal?s best employers, as part of the Canada?s Top 100 Employers project. Pharmascience Inc. has strong long-standing philanthropic ties with its communities, both locally and internationally. For more than 20 years, Pharmascience has been working through Health Partners International of Canada (HPIC) as the partner of choice to increase access to medicine. Pharmascience?s total donations of essential medicine, is close to $60 million. Pharmascience Inc. is a leading manufacturer and marketer of prescription; generic, over-the-counter, and behind-the-counter products as well as FDA approved Canadian-made injectables. Pharmascience Inc. commercializes nearly 400 product families in 20 different dosage forms for over 2,000 products. In Canada alone, more than 45 million prescriptions a year are filled with Pharmascience products. For more information, please visit 


Back to News